204 related articles for article (PubMed ID: 18490728)
1. Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cells.
van der Vliet HJ; Wang R; Yue SC; Koon HB; Balk SP; Exley MA
J Immunol; 2008 Jun; 180(11):7287-93. PubMed ID: 18490728
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
[TBL] [Abstract][Full Text] [Related]
3. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
[TBL] [Abstract][Full Text] [Related]
4. Impaired SLAM-SLAM homotypic interaction between invariant NKT cells and dendritic cells affects differentiation of IL-4/IL-10-secreting NKT2 cells in nonobese diabetic mice.
Baev DV; Caielli S; Ronchi F; Coccia M; Facciotti F; Nichols KE; Falcone M
J Immunol; 2008 Jul; 181(2):869-77. PubMed ID: 18606638
[TBL] [Abstract][Full Text] [Related]
5. Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells.
Montoya CJ; Jie HB; Al-Harthi L; Mulder C; Patiño PJ; Rugeles MT; Krieg AM; Landay AL; Wilson SB
J Immunol; 2006 Jul; 177(2):1028-39. PubMed ID: 16818759
[TBL] [Abstract][Full Text] [Related]
6. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni.
Mallevaey T; Zanetta JP; Faveeuw C; Fontaine J; Maes E; Platt F; Capron M; de-Moraes ML; Trottein F
J Immunol; 2006 Feb; 176(4):2476-85. PubMed ID: 16456008
[TBL] [Abstract][Full Text] [Related]
7. IL-7 During Antigenic Stimulation Using Allogeneic Dendritic Cells Promotes Expansion of CD45RA
Trujillo-Ocampo A; Cho HW; Clowers M; Pareek S; Ruiz-Vazquez W; Lee SE; Im JS
Front Immunol; 2020; 11():567406. PubMed ID: 33329531
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
[TBL] [Abstract][Full Text] [Related]
9. CD1d and invariant NKT cells at the human maternal-fetal interface.
Boyson JE; Rybalov B; Koopman LA; Exley M; Balk SP; Racke FK; Schatz F; Masch R; Wilson SB; Strominger JL
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13741-6. PubMed ID: 12368486
[TBL] [Abstract][Full Text] [Related]
10. CD1d-restricted "NKT" cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses?
Gumperz JE
J Leukoc Biol; 2004 Aug; 76(2):307-13. PubMed ID: 15123775
[TBL] [Abstract][Full Text] [Related]
11. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
12. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
[TBL] [Abstract][Full Text] [Related]
13. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
[TBL] [Abstract][Full Text] [Related]
14. The A2aR adenosine receptor controls cytokine production in iNKT cells.
Nowak M; Lynch L; Yue S; Ohta A; Sitkovsky M; Balk SP; Exley MA
Eur J Immunol; 2010 Mar; 40(3):682-7. PubMed ID: 20039304
[TBL] [Abstract][Full Text] [Related]
15. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
16. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
17. Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation.
Sakuishi K; Oki S; Araki M; Porcelli SA; Miyake S; Yamamura T
J Immunol; 2007 Sep; 179(6):3452-62. PubMed ID: 17785779
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
Gigli G; Caielli S; Cutuli D; Falcone M
Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
[TBL] [Abstract][Full Text] [Related]
20. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation.
Salio M; Speak AO; Shepherd D; Polzella P; Illarionov PA; Veerapen N; Besra GS; Platt FM; Cerundolo V
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20490-5. PubMed ID: 18077358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
